Nov 10, 2026
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
TherapeuticsMD Inc. (TXMD) stock rose 2.96% to $1.74 on a generally down day for the market, outperforming the NASDAQ Composite and Dow Jones Industrial Average. The company's shares closed 41.02% below their 52-week high of $2.95, achieved on January 27th.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish
Nov 9, 2026
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors
Shares of TherapeuticsMD Inc. (TXMD) fell 2.87% to $1.69 on Monday, even as the broader market, including the NASDAQ Composite Index and Dow Jones Industrial Average, saw significant gains. The stock closed 42.71% below its 52-week high of $2.95, reached on January 27th.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Bearish
Nov 6, 2026
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
Shares of TherapeuticsMD Inc. (TXMD) rose 1.75% to $1.74 on Friday, outperforming some competitors despite a mixed trading session for the broader market. The NASDAQ Composite Index saw gains while the Dow Jones Industrial Average declined. The company's stock is currently 41.02% below its 52-week high reached on January 27th.
Company relevance
100.00%
Company sentiment
Somewhat-Bullish
Overall sentiment
Somewhat-Bullish
Nov 5, 2026
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors
Shares of TherapeuticsMD Inc. (TXMD) fell 6.04% on Thursday, closing at $1.71, as the broader market also experienced a downturn with the NASDAQ Composite and Dow Jones Industrial Average both declining. The company's stock is now trading 42.03% below its 52-week high of $2.95, reached on January 27th. This performance highlights an underperformance compared to its competitors amidst a grim trading session.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Bearish
Nov 3, 2026
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors
Shares of TherapeuticsMD Inc. (TXMD) fell 1.66% on Tuesday, closing at $1.78, in a mixed trading session for the broader stock market. The NASDAQ Composite rose while the Dow Jones Industrial Average declined. The company's stock is currently 39.66% below its 52-week high of $2.95, reached on January 27th.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Bearish
Oct 30, 2026
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors
Shares of TherapeuticsMD Inc. (TXMD) fell 1.64% on Friday, closing at $1.80, a performance that trailed behind the broader market indices. This decline occurred during a generally weak trading session, with the NASDAQ Composite Index down 2.86% and the Dow Jones Industrial Average falling 1.09%. The stock's dip ended a two-day winning streak for the company.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Bearish
Oct 29, 2026
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
TherapeuticsMD Inc. (TXMD) saw its stock advance 2.23% to $1.83 on Thursday, outperforming the broader market. This gain occurred despite a challenging trading session where the NASDAQ Composite Index fell 1.38% and the Dow Jones Industrial Average dropped 0.25%. This marks the second consecutive day of gains for TherapeuticsMD Inc. stock.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish